Adagio Medical Holdings, Inc. received a notice from Nasdaq on June 12, 2026, stating its common stock is not in compliance with the Minimum Bid Price Requirement. The company's stock price fell below $1.00 per share for 30 consecutive business days. Adagio has 180 days, until December 9, 2026, to regain compliance by maintaining a closing price of at least $1.00 for ten consecutive trading days. Failure to comply may lead to a second 180-day period involving a potential reverse stock split or eventual delisting. The company is evaluating options to meet listing standards. Adagio Medical Holdings, Inc. is a medical technology company.